Takehiko Mori

39PUBLICATIONS
65CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 07, 2026
Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological event.

|Jan 20, 2026
Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy.

Yoshihiro Umezawa, Masahide Yamamoto, Keisuke Tanaka

|Dec 22, 2025
Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia.

Yuma Noguchi, Takehiko Mori, Yasushi Onishi

|Mar 21, 2024
Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation.

Yoshihiro Umezawa, Kota Yoshifuji, Keisuke Tanaka

|Feb 10, 2024
Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.

Ryusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto

|Jul 27, 2022
Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer.

Rika Noji, Kohki Tohyama, Takuma Kugimoto

Pageof 7

Frequent Collaborators

4 joint publications

Yoshiko Atsuta

4 joint publications

Junya Kanda

4 joint publications

Jun Kato

3 joint publications

Masahide Yamamoto